Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial
Topical dorzolamide was safe but not superior to placebo in the functional and anatomical outcomes of FTMH.
Authors
- Yong Min Lee (ORCID: https://orcid.org/0000-0003-3358-8894)
- Wilson W. Wong (ORCID: https://orcid.org/0000-0001-8394-889X)
- Montserrat Maria Bausili
- Shane R. Durkin
- Stewart Lake (ORCID: https://orcid.org/0000-0003-0078-3319)
- Premala Devi Sivagurunathan
- David Sia (ORCID: https://orcid.org/0000-0003-0749-7614)
- Dinesh Selva (ORCID: https://orcid.org/0000-0002-2169-5417)
- Bobak Bahrami (ORCID: https://orcid.org/0000-0003-1057-5142)
- Jagjit S. Gilhotra (ORCID: https://orcid.org/0000-0002-8713-7733)
- Robert J. Casson (ORCID: https://orcid.org/0000-0003-2822-4076)
- Surbhi Agrawal (ORCID: https://orcid.org/0000-0002-1155-491X)
- Duleepa Baranage
- Weng Onn Chan
Institutions
- Royal Adelaide Hospital (AU)
- Flinders Medical Centre (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Clinical and Experimental Ophthalmology
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1111/ceo.14432
- Citations
- 4
- Primary Topic
- Retinal and Macular Surgery
- Type
- article
- Field-Weighted Citation Impact
- 1.62
Funders
- University of Adelaide